Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque, Gérard M. London, Ziad Massy, Petro Ruggenenti, Esteban Porrini, Andrzej Wiecek, Carmine Zoccali, Francesca Mallamaci, Mads Hornum

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) 34:2 (208–230) DOI:10.1093/ndt/gfy407)'. Together they form a unique fingerprint.

Medicine & Life Sciences